Objective: The purpose of this study is to estimate the maternal and fetal morbidities associated with asynchronous delivery.
Methods: A review of maternal and fetal medical records was performed at 2 tertiary care centers over 12 years. Charts were identified by the International Classification of Diseases, 9th Revision, Clinical Modification codes for twin and triplet gestations.
Objective: To determine whether magnesium sulfate prevents disease progression in women with mild preeclampsia.
Methods: A total of 222 women with mild preeclampsia were randomized to receive intravenous magnesium sulfate (n = 109) or matched placebo (n = 113). Mild preeclampsia was defined as blood pressure of at least 140/90 mm Hg taken on two occasions in the presence of new-onset proteinuria.